Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans

British Journal of Pharmacology

Volumn 126, Issue 4, 1999, Pages 989-996

  Malis, Didier David ^a   Grouzmann, Eric ^b   Morel, Denis R ^a   Mutter, Manfred ^c   Lacroix, Jean Silvain ^a  

^a Faculty of Medicine   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c NONE

Author keywords

Allergic rhinitis; Histamine; Nasal mucosa; Neuropeptide Y (NPY); Pig; TASP V; Y2 receptor analogue

Indexed keywords

HISTAMINE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BRONCHOSPASM; BRONCHUS REACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORMAL HUMAN; NOSE AIRWAY RESISTANCE; NOSE MUCOSA; PRIORITY JOURNAL; PROVOCATION TEST; SWINE;

EID: 0032957160     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702388     Document Type: Article

References (69)

1. Alving, K. (1991). Airways vasodilatation in the immediate allergic reaction: involvement of inflammatory mediators and sensory nerves. Acta Physiol. Scand., 141, (suppl 597) 1-64.
2. Alving, K., Sundstrom, C., Matran, R., Panula, P., Hokfelt, T. & Lundberg, J.M. (1991). Association between histamine-containing mast cells and sensory nerves in the skin and airways of control and capsaicin-treated pigs. Cell Tissue Res., 264, (3) 529-538.
3. Amann, R., Schuligoi, R., Lanz, I. & Donnerer, J. (1995). Histamine-induced oedema in the rat paw effect of capsaicin denervation and a CGRP receptor antagonist. Eur. J. Pharmacol., 279, (2-3) 227-231.
4. Baraniuk J.N., Silver, P.B., Kaliner, M.A. & Barnes, P.J. (1992). Neuropeptide Y is a vasoconstrictor in human nasal mucosa. J. Appl. Physiol., 73, (5) 1867-1872.
5. Bayliss, W.M. (1901). On the origin from the spinal cord of the vasodilator fibres of the hind limb and on the nature of these fibres. J. Physiol., 26, 173-209.
6. Broms, P., Ivarsson, A. & Jonson, B. (1982a). Rhinomanometry I. Simple equipment. Acta Otolaryngol., 93, 455.
7. Broms, P., Jonson, B. & Lamm, C.J. (1982b). Rhinomanometry II. A system for numerical description of nasal airway resistance. Acta Otolaryngol., 94, 157-168.
8. Colander, O. & Folkow, B. (1953). The nature and distribution of afferent fibres provided with axon reflex arrangement. Acta Physiol. Scand., 29, 359-370.
9. Cole, P. (1989). Rhinomanometry: practice and trends. Layngoscope. 90, 311-315.
10. Doidge, J.M. & Satchell, D.G. (1982). Adrenergic and non-adrenergic inhibitory nerves in mammalian airways. J. Auton. Nervous System. 5, 83-99.
11. Eccles, R. & Wilson, H. (1973). The parasympathetic secretory nerves of the nose of the cat. J. Physiol., 230, 213-223.
12. Ekblad, E., Edvinsson, L., Wahlenstedt, C., Uddmann, R., Hakanson, R & Sundler, F. (1984). Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul. Peptides, 8, 225-235.
13. Erjavec, F., Lembeck, F., Florjanc-Irman, T., Skofitsch, G., Donnerer, BJ, Saria, A. & Holzer, P. (1981). Release of histamine by substance P. Arch. Pharmacol., 317, 67-70.
14. Fouke, J.M. & Jackson, A. (1992). Acoustic rhinometry: effects of decongestants and posture on nasal patency. J. Lab. Clin. Med., 19, 371-376.
15. Fuhlendorff, J., Gether, U., Aakerlund, L., Langeland-Johensen, N., Tøgerson, H., Melberg, S.G., Olsen, U.B., Thastrup, O. & Schwarz, T.V. (1990). [Leu31, Pro34] Neuropeptide Y: a specific Y1-receptor agonist. Proc. Natl. Acad. Sci. U.S.A., 87, 182-185.
16. 2 antagonist. J. Biol. Chem., 272, (12) 7699-7706.
17. 2) and its effect on inferior olivary neurones. Eur. J. Biochem., 234, (1) 44-49.
18. Hilberg, O., Jackson, A.C., Swift, D.L. & Pedersen, O.F. (1989). Acoustic rhinometry: evaluation of nasal cavity geometry by acoustic reflection. J. Appl. Physiol., 66, 295-303.
19. Huttunen, M., Harvima, I.T., Ackermann, L., Harvima, R.J., Naukkarinen, A. & Horsmanheimo, M. (1996). Neuropeptide-and capsaicin-induced histamine release in skin monitored with the microdialysis technique. Acta Derm. Venereol., 76, (3) 205-209.
20. 3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. Circ. Res., 78, (5) 863-869.
21. Jancso, N., Jancso-Gabor, A. & Szolcsanyi, I. (1967). Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmac. Chemother., 31, 138-151.
22. Lacroix, J.S. (1989). Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol. Scand., 136, (suppl. 581) 1-63.
23. Lacroix, J.S., Anggård, A., Hökfelt, T., O'Hare, T., Fahrenkrug, J. & Lundberg, J.M. (1990). Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa. Cell Tissue Res., 259, 119-128.
24. Lacroix, J.S., Buvelot, J.M., Polla, B.S. & Lundberg, J.M. (1991). Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin. Exp. Allergy, 21, 595-600.
25. Lacroix, J.S. & Lundberg, J.M. (1994). Neural reflex pathways in rhinitis. In: Asthma and Rhinitis. W.W. Busse and S.T. Holgate (eds.) Vol. 52, pp. 686-690 London: Blackwell.
26. Lacroix, J.S. & Mosimann, B.L. (1996). Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients. J. Allergy Clin. Immunol., 98, 611-616.
27. Lacroix, J.S., Ricchetti, A.P., Morel, D., Mosimann, B., Wäbber, B. & Grouzmann, E. (1996). Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects. Br. J. Pharmacol., 118, 2079-2084.
28. Lacroix, J.S., Stjärne, P., Änggård, A., Lundberg, J.M. (1988). Sympathetic vascular control of the pig nasal mucosa: (I) increased resistance and capacitance vessel responses upon stimulation with irregular bursts compared to continuous impulses. Acta Physiol. Scand., 132, 83-90.
29. Lacroix, J.S., Ulman, L.G. & Potter, E.K. (1994a). Sympathetic and parasympathetic interaction in vascular control of the nasal mucosa in anaesthetized cats. J. Physiol. (Lond.), 480, 325-331.
30. 2 prejunctional receptor. Br. J. Pharmacol., 113, 479-484.
31. Lowman, M.A., Benyon, R.C. & Church, M.K. (1988). Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br. J. Pharmacol., 95, (1) 121-130.
32. Lundberg, J.M., Lundblad, L. & Anggård, A. (1988). Bioactive peptides in capsaicin-sensitive C-fibre afferents of the airways. Functional and pathophysiological implications. In: The airways. Neural control in health and disease. Kaliner, M.A. and Barnes, P.I. eds. pp. 417-445. New York: Marcel Dekker.
33. Lundberg, J.M. & Saria, A. (1983). Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature, 17, 302 (5905) 251-253.
34. Lundberg, J.M., Terenius, L., Hökfelt, T., Martling, C.R., Tatemoto, K., Mutt, V., Polak, J., Bloom, S.R. & Goldstein, M. (1982). Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic nerves and effect of NPY on sympathetic function. Acta Physiol. Scand., 116, 477-480.
35. Lunblad, L. (1984). Protective reflexes and vascular effects in the nasal mucosa elicited by activation of capsaicin sensitive substance P-immunoreactive neurons. Acta Physiol. Scand. Suppl., 529, 1-42.
36. Malm, L. (1973). Stimulation of sympathetic nerve fibres to the nose in cats. Acta Otolaryngol., 75, 519-526.
37. Mann, S.P. (1971). The innervation of mammalian bronchial smooth muscle: the localization of catecholamines and cholinesterase. Histochem. J., 3, 319-331.
38. 2-adrenoceptors and opiate receptors. Eur. J. Pharmacol., 163, 15-23.
39. Mosimann, B., White, M.V., Hohman, R.J., Goldrich, M.S., Kaulbach, H.C. & Kaliner, M.A. (1993). Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J. Allergy Clin. Immunol., 92, 95-104.
40. Mutter, M. (1988). Nature's rules and chemist's tools: a way for creating novel proteins. Trends Biochem. Sci., 13, 260-265.
41. Mutter, M., Altmann, E., Altmann, K.H., Hersperger, R., Koziej, P., Nebel, K. & Tuchscherer, G. (1988). The construction of new proteins. Part iii. Artificial folding units by assembly of amphiphilic secondary structures on a template. Helv. Chim. Acta, 71, 835-847.
42. Mutter, M., Dumy, P., Garrouste, P., Lehmann, C., Mathieu, M., Peggion, C., Peluso, S., Razaname, A. & Tuchscherer, G. (1996). Template assembled synthetic peptides (TASP) as functional mimetics of proteins. Angewandte Chemie, Int. Ed. Engl., 35, (13/14) 1482-1485.
43. Mutter, M., Tuchscherer, G., Miller, C., Altmann, K.H., Carey, R.I., Wyss, D.F., Labhardt, A.M. & Rivier, J.E. (1992). Template-assembled synthetic proteins with four-helix-bundle topology. Total chemical synthesis and conformational studies. J. Am. Chem. Soc., 114, 1463-1470.
44. Nuki, C., Kawasaki, H. & Takasaki, K. (1990). Effect of neuropeptide Y on vasodilation mediated by calcitonin gene-related peptide (CGRP)-containing nerves in the mesenteric resistance vessel of the rat. Jpn. J. Pharmacol., 53, (1) 125-128.
45. Ottosson, A. & Edvinsson, L. (1997). Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia, 17, (3) 166-174.
46. Pack, R.J. & Richardson, P.S. (1984). The aminergic innervation of the human bronchus: a light and electron microscopic study. J. Anal., 138, 493-502.
47. Partanen, M., Laitinen, A., Hervonen, A., Toivanen, M. & Laitinen, L.A. (1982). Catecholamine-and acetylcholin-esterase-containing nerves in human lower respiratory tract. Histochemistry, 76, 175-188.
48. Pernow, J. (1988). Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control. Acta Physiol. Scand., 133, Supp 568 1-56.
49. Piotrowski, W. & Foreman, J.C. (1986). Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br. J. Dermatol., 114, (I) 37-46.
50. Potter, E.K., Barden, J.A., McCloskey, M.J.D., Selbie, L.A., Tseng, A., Herzog, H. & Shine, J. (1994). A novel neuropeptide Y analog, N-acetyl [Leu28, Leu31] NPY24-36, with functional specificity for the presynaptic (Y2) receptor. Eur. J. Pharmacol., 267, 253-262.
51. Proud, D., Togias, A., Nacleirio, R.M., Crush, S.A., Norman, P.S. & Lichtenstein, L.M. (1983). Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J. Clin. Invest., 72, 1678-1685.
52. Rangi, S.P., Sample, S., Serwonska, M.H., Lenahan, G.A. & Götzl, E.J. (1990). Mediation of prolonged increases in nasal mucosal blood flow by calcitonin gene-related peptide (CGRP). J. Clin. Immunol., 10, (6) 304-310.
53. Revington, M., Lacroix, J.S. & Potter, E.K. (1997). Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs. J. Physiol., 505, (Pt 3) 823-831.
54. Sandor, A., Kidd, M., Lawton, G.P., Miu, K., Tang, L.H. & Modlin, I.M. (1996). Neurohormonal modulation of rat enterochromaffin-like cell histamine secretion. Gastroenterology, 110, (4) 1084-1092.
55. Schumacher, M.J. (1989). Rhinomanometry. J. Allergy Clin. Immunol., 83, 711-718.
56. Stead, R., Bienenstock, J. & Stanisz, A. (1987). Neuropeptide regulation of mucosal immunity. Immunol. Rev., 10, 333-359.
57. Stjärne, P. (1991). Sensory and motor reflex control of nasal mucosal blood flow and secretion; clinical implications in non-allergic nasal hyperreactivity. Acta Physiol. Scand. Suppl., 600, 1-64.
58. Stretton, C.D. & Barnes, P.J. (1988). Modulation of cholinergic neurotransmission in guinea-pig trachea by NPY. Br. J. Pharmacol., 93, 672-678.
59. Stricker, S. (1876). Untersuchungen über die Gefässwurzeln des Ischiadicus. Stitz-Ber. Kaiserl. Akad. Wiss., 3, 173-175.
60. Takeda, N., Kalubi, B., Abe, Y., Irifune, M., Ogino, S. & Matsunaga, T. (1993). Neurogenic inflammation in nasal allergy: histochemical and pharmacological studies in guinea pigs. A review. Acta Otolaryngol. Suppl., 501, 21-24.
61. Tani, E. & Ishikawa, T. (1990). Histamine acts directly on calcitonin gene-related peptide-and substance P-containing trigeminal ganglion neurons as assessed by calcium influx and immunocytochemistry. Auris Nasus Larynx, 17, (4) 267-274.
62. Tani, E., Shiosaka, S., Sato, M., Ishikawa, T. & Tohyama, M. (1990). Histamine acts directly on calcitonin gene-related peptide-and substance P-containing trigeminal ganglion neurons as assessed by calcium influx and immunocytochemistry. Neurosci. Lett., 115, (2-3) 171-176.
63. Tatemoto, K. (1982). Neuropeptide Y complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. U.S.A., 79, 5485-5489.
64. Tatemoto, K., Carlquist, M. & Mutt, V. (1982). Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature, 296, (5858) 659-660.
65. Wahlestedt, C., Edvinsson, L., Ekblad, E. & Hakanson, R. (1985). Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J. Pharmacol. Exp. Ther., 234, (3) 735-741.
66. Wahlestedt, C., Yanaihara, N. & Häkanson, R. (1986). Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul. Peptides, 13, 307-318.
67. Warner, M.R. & Levy, M.N. (1989). Neuropeptide Y as a putative modulator of the vagal effect on the heart rate. Circ. Res., 64, 882-889.
68. Westfall, T.C., Carpentier, S., Chen, X., Beinfeld, M.C., Naes, L. & Meldrum, M.J. (1987). Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J. Cardiovasc. Pharmacol., 10, 716-722.
69. White, M.V., Kowalski, M.L. & Kaliner, M.A. (1989). Mast cell secretagogues. In Biochemistry of the Acute Allergic Reactions: Fifth International Symposium. Tauber, A.I., Wintroub, B.U. and Simon, A.S. eds. pp. 83-101. New York: Alan R. Liss Inc.